Severe Asthma with Fungal Sensitization
The DOI matches its Crossref record; 128 of the 128 references it cites were found in a registry or an index.
Abstract
A new phenotype of asthma has been described recently, namely severe asthma with fungal sensitization (SAFS). SAFS can be conceptualized as a continuum of fungal sensitization, with asthma at one end and allergic bronchopulmonary aspergillosis at the other. It is diagnosed by the presence of severe asthma, fungal sensitization, and exclusion of allergic bronchopulmonary aspergillosis. Because of the paucity of data and ambiguity in diagnostic criteria, SAFS is currently more of a diagnosis of exclusion than a specific entity. Treatment of SAFS initially should be similar to that of severe asthma, including the use of omalizumab. The potential role of itraconazole as a specific therapy in SAFS requires more evidence before it can be incorporated in routine practice. An urgent need exists for data regarding the prevalence, natural history, and clinical relevance of SAFS so that its exact characterization and importance as a specific subtype of asthma can be clearly defined. This review summarizes the current understanding of the pathogenesis, diagnosis, and management of SAFS.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Patients with SAFS probably constitute a significant proportion (~50% estimated) of the nearly 0.5 million asthma related deaths worldwide [148,149].”
From Global and Multi-National Prevalence of Fungal Diseases-Estimate Precision (2017) · cites this paper as [148]
Citations
Cites
GLOBAL STRATEGY FOR ASTHMA MANAGEMENT AND PREVENTION
PAUWELS, R. A. (1996) · Arerugī/Arerugi · doi:10.15036/arerugi.45.792 · Cited by 9,994
Expert Panel Report 2: Guidelines for the Diagnosis and Management of Asthma
Program, P., & theDiagnosis, T. E. P. O. (1997) · Cited by 4,926
(2007) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2007.09.029 · Cited by 2,181
British Guideline on the Management of Asthma
British Thoracic Society Scottish Intercollegiate Guidelines Network (2008) · Thorax · doi:10.1136/thx.2008.097741 · Cited by 2,021
National Asthma Education and Prevention Program
VanGraafeiland, B. (2002) · The Nurse Practitioner · doi:10.1097/00006205-200206001-00003 · Cited by 1,091
Moore, W. C., Bleecker, E. R., Curran-Everett, D., Erzurum, S. C., Ameredes, B. T., Bacharier, L., Calhoun, W. J., Castro, M., Chung, K. F., Clark, M. P., et al. (2007) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2006.11.639 · Cited by 929 · cited 1×
“asthma manifest with severe disease, which leads to considerable limitation of activities of daily life and can be fatal [2].”
Background(2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.162.6.ats9-00 · Cited by 909
The link between fungi and severe asthma: A summary of the evidence
Denning, D. W., O'Driscoll, B. R., Hogaboam, C. M., Bowyer, P., & Niven, R. M. (2006) · European Respiratory Journal · doi:10.1183/09031936.06.00074705 · Cited by 824 · cited 2×
“More recently, the term severe asthma with fungal sensitization (SAFS) has been coined to define a particular phenotype of severe asthma, with possible therapeutic implications [8].”
BackgroundClinical and Immunologic Criteria for the Diagnosis of Allergic Bronchopulmonary Aspergillosis
ROSENBERG, M., PATTERSON, R., MINTZER, R., COOPER, B. J., ROBERTS, M., & HARRIS, K. E. (1977) · Annals of Internal Medicine · doi:10.7326/0003-4819-86-4-405 · Cited by 819
O'Hollaren, M. T., Yunginger, J. W., Offord, K. P., Somers, M. J., O'Connell, E. J., Ballard, D. J., & Sachs, M. I. (1991) · New England Journal of Medicine · doi:10.1056/nejm199102073240602 · Cited by 694 · cited 2×
“A decade later, an association of Alternaria spp sensitivity and increased risk of respiratory arrest was shown in 11 asthmatics [18].”
Background
Cited by
Global and Multi-National Prevalence of Fungal Diseases-Estimate Precision
Bongomin, F., Gago, S., Oladele, R., & Denning, D. (2017) · Journal of Fungi · doi:10.3390/jof3040057 · Cited by 2,953
“5 million asthma related deaths worldwide [148,149].”
Agarwal, R., Chakrabarti, A., Shah, A., Gupta, D., Meis, J. F., Guleria, R., Moss, R., Denning, D. W., & ABPA complicating asthma ISHAM working group (2013) · Clinical & Experimental Allergy · doi:10.1111/cea.12141 · Cited by 896
Self-citationTestosterone Attenuates Group 2 Innate Lymphoid Cell-Mediated Airway Inflammation
Cephus, J.-Y., Stier, M. T., Fuseini, H., Yung, J. A., Toki, S., Bloodworth, M. H., Zhou, W., Goleniewska, K., Zhang, J., Garon, S. L., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.10.110 · Cited by 295
“Mouse in vivo experiments revealed that lung ILC2 have a critical role in rapid Th2-type inflammation in response to protease aeroallergens such as Alternaria alternata, which is associated with severe exacerbations of asthma (Agarwal, 2011; Dales et al., 2000; Neukirch et al., 1999; Zureik et al., 2002).”
BackgroundAlternaria-derived serine protease activity drives IL-33–mediated asthma exacerbations
Snelgrove, R. J., Gregory, L. G., Peiró, T., Akthar, S., Campbell, G. A., Walker, S. A., & Lloyd, C. M. (2014) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2014.02.002 · Cited by 263
Fungi: the neglected allergenic sources
Crameri, R., Garbani, M., Rhyner, C., & Huitema, C. (2014) · Allergy · doi:10.1111/all.12325 · Cited by 207
“Because of the ambiguity in diagnostic criteria, SAFS is currently more a diagnosis by exclusion than a diagnosis of a specific disease entity (55).”
Background
Metadata
- Authors
- Agarwal, R.
- Affiliations
- Post Graduate Institute of Medical Education and Research (IN)
- Corresponding author
- Agarwal, Ritesh
- ORCID
- Agarwal, Ritesh
- Venue
- Current Allergy and Asthma Reports
- Published
- 2011-07-26
- Volume
- 11
- Issue
- 5
- Pages
- 403-413
- ISSN
- 1529-7322 (ISSN-L)
- 1534-6315
- OpenAlex
- W2150859631
- Cited by
- 188
- References
- 128
- Citations by year
- 2026: 8 · 2025: 4 · 2024: 8 · 2023: 9 · 2022: 9 · 2021: 21 · 2020: 13 · 2019: 20 · 2018: 17 · 2017: 23 · 2016: 15 · 2015: 7 · 2014: 12 · 2013: 12 · 2012: 8
- FWCI
- 1.16
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Current Allergy and Asthma Reports (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Asthma and respiratory diseases
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Occupational exposure and asthma
- Keywords
- allergic bronchopulmonary aspergillosis, fungal sensitization, asthma phenotypes, omalizumab, itraconazole, asthma pathogenesis, asthma diagnosis, asthma management
- MeSH terms
- Omalizumab, Animals, Antibodies, Anti-Idiotypic, Antifungal Agents, Aspergillosis, Allergic Bronchopulmonary, Asthma, Humans, Severity of Illness Index, Itraconazole, Anti-Asthmatic Agents, Antibodies, Monoclonal, Humanized
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Severe Asthma with Fungal Sensitization. https://app.cochat.ai/papers/10.1007/s11882-011-0217-4
- The paper
- Agarwal, R. (2011). Severe Asthma with Fungal Sensitization. Current Allergy and Asthma Reports. https://doi.org/10.1007/s11882-011-0217-4
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.